Skip to main content

The Measurement of Receptor Signaling Bias

  • Protocol
G Protein-Coupled Receptors in Drug Discovery

Part of the book series: Methods in Molecular Biology ((MIMB,volume 1335))

Abstract

This chapter describes a method to quantify biased signaling effects of agonists; this approach can furnish a scale for medicinal chemists to optimize biased profiles. Biased ligands have different pharmacological properties on a molecular level (stabilization of different receptor active states) and thus can have different pharmacological profiles therapeutically. The calculation of transduction ratios (ΔΔlog(τ/K A)) values (where τ is efficacy and K A a measure of affinity) allows the identification of agonists that demonstrate unique signaling either for different signaling pathways linked to the receptor, differences in cellular host, effects of receptor mutation, or receptor selectivity profiles. The procedure includes statistical methods to assess the significance of these effects.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Kenakin TP, Watson C, Muniz-Medina V, Christopoulos A, Novick S (2012) A simple method for quantifying functional selectivity and agonist bias. ACS Chem Neurosci 3:193–203

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  2. Kenakin TP (1995) Agonist-receptor efficacy II: agonist-trafficking of receptor signals. Trends Pharmacol Sci 16:232–238

    Article  CAS  PubMed  Google Scholar 

  3. Mailman RB (2007) GPCR functional selectivity has therapeutic impact. Trends Pharmacol Sci 28:390–396

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  4. Perez DM, Karnick SS (2005) Multiple signaling states of G-protein coupled receptors. Pharmacol Rev 57:147–161

    Article  CAS  PubMed  Google Scholar 

  5. Kenakin T (2013) New concepts in pharmacological efficacy at 7TM receptors: IUPHAR review 2. Br J Pharmacol 168(3):554–575

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  6. Kenakin TP, Miller LJ (2010) Seven transmembrane receptors as shapeshifting proteins: the impact of allosteric modulation and functional selectivity on new drug discovery. Pharmacol Rev 62:265–304

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  7. Liu JJ et al (2012) Biased signaling pathways in β2-adrenergic receptor characterized by 19F-NMR. Science 335:1106–1110

    Google Scholar 

  8. Tilley DG (2011) G protein-dependent and G protein-independent signaling pathways and their impact on cardiac function. Circ Res 109:217–230

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  9. Tilley DG (2011) Functional relevance of biased signaling at the angiotensin II type 1 receptor. Endocr Metab Immune Disord Drug Targets 11:99–111

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  10. Urban JD, Vargas GA, von Zastrow M, Mailman RB (2007) Aripiprazole has functionally selective action at dopamine D2 receptor-mediated signaling pathways. Neuropsychopharmacology 32:67–77

    Article  CAS  PubMed  Google Scholar 

  11. Bohn L, Lefkowitz RJ, Gainetdinov RR, Peppel K, Caron MG, Lin F-T (1999) Enhanced morphine analgesia in mice lacking beta-arrestin 2. Science 286:2495–2498

    Article  CAS  PubMed  Google Scholar 

  12. Bohn LM, Schmid CL (2010) Serotonin receptor signaling and regulation via β-arrestins. Crit Rev Biochem Mol Biol 45:555–566

    Article  CAS  PubMed  Google Scholar 

  13. DeWire SM, Ahn S, Lefkowitz RJ, Shenoy SK (2007) Beta arrestins and cell signaling. Annu Rev Physiol 69:483–510

    Article  CAS  PubMed  Google Scholar 

  14. Gesty-Palmer D, Flannery P, Yaun L et al (2009) A β-arrestin–biased agonist of the parathyroid hormone receptor (PTH1R) promotes bone formation independent of G protein activation. Sci Transl Med 1:1ra1

    PubMed Central  PubMed  Google Scholar 

  15. Ehlert FJ (2005) Analysis of allosterism in functional assays. J Pharmacol Exp Ther 315:740–754

    Article  CAS  PubMed  Google Scholar 

  16. Figueroa KW et al (2009) Selectivity of agonists for the active state of the M1 to M4 muscarinic receptor subtypes. J Pharmacol Exp Ther 328:331–342

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  17. Tran JA et al (2009) Estimation of the relative microscopic affinity constants of agonists for the active state of the receptor in functional studies on M2 and M3 muscarinic receptors. Mol Pharmacol 75:381–396

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  18. Black JW, Leff P (1983) Operational models of pharmacological agonist. Proc R Soc Lond Biol 220:141–162

    Article  CAS  PubMed  Google Scholar 

  19. Black JW, Leff P, Shankley NP (Appendix J. Wood) (1985) An operational model of pharmacological agonism: the effect of E/[A] curve shape on agonist dissociation constant estimation. Br J Pharmacol 84:561–571

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Terry Kenakin .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Science+Business Media New York

About this protocol

Cite this protocol

Kenakin, T. (2015). The Measurement of Receptor Signaling Bias. In: Filizola, M. (eds) G Protein-Coupled Receptors in Drug Discovery. Methods in Molecular Biology, vol 1335. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-2914-6_11

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-2914-6_11

  • Publisher Name: Humana Press, New York, NY

  • Print ISBN: 978-1-4939-2913-9

  • Online ISBN: 978-1-4939-2914-6

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics